← Leaderboards
James Arthur Raleigh
University Of North Carolina Chapel Hill
$1,033,497
Attributed
$1,033,497
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,033,497 · 4
By mechanism
R01$724,383 · 1
R41$309,114 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Chapel Hill
Same institution · by research overlap
- Eric C. Frey$18,016,002
- Kuo-Hsiung Lee$16,683,783
- Scott H Donaldson$8,054,486
- Alicja Bielawska$7,829,586
- Kim L Brouwer$15,343,248
Others in their field
Top investigators on “Hypoxia”
- James B Edson · Woods Hole Oceanographic Institution$110,367,520
- Albert J Plueddemann · Woods Hole Oceanographic Institution$110,367,520
- David Heimbrook · Leidos Biomedical Research, Inc.$41,862,534
- Nanduri R Prabhakar · Case Western Reserve University$32,967,177
- Zaver M Bhujwalla · Johns Hopkins University$30,055,665
- Donna M. Ferriero · University Of California, San Francisco$27,259,560
Research focus
HypoxiaBcl2 Gene /ProteinNeoplastic GrowthComplementary DnaGene ExpressionHuman TissueIn Situ HybridizationKeratinMetallothioneinMicroarray TechnologyNeoplasm /Cancer GeneticsApoptosisProliferating Cell Nuclear AntigenSquamous Cell CarcinomaTechnology /Technique DevelopmentBiomarkerImidazoleImmunochemistryEnzyme Linked Immunosorbent AssayImmunologic Substance Development /PreparationPharmacokineticsIntravenous AdministrationPositron Emission TomographyTissue /Cell Culture
Grant awards (6)
Oral Pimonidazole$111,879
R41 · FY2004 · CA
HYPOXIA AND GENE EXPRESSION IN HUMAN TUMORS$241,530
R01 · FY2003 · CA
HYPOXIA AND GENE EXPRESSION IN HUMAN TUMORS$241,530
R01 · FY2002 · CA
HYPOXIA AND GENE EXPRESSION IN HUMAN TUMORS$241,323
R01 · FY2001 · CA
PET Reagents for Normal and Tumor Tissue Hypoxia$99,515
R41 · FY2001 · CA
Molecular Markers for Tissue Hypoxia$97,720
R41 · FY2001 · CA